Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.
Lynn Turner MatthewsManjeetha JaggernathYolandie KrielPatricia M SmithKasey O'NeilJessica E HabererCraig HendrixJared M BaetenNorma C WareKathleen WirthChristina PsarosDavid R BangsbergJennifer A SmitPublished in: BMJ open (2019)
The protocol is registered with the South African Health Products Regulatory Agency (SAHPRA, formerly known as the Medicine Controls Council, MCC#20170131) and ClinicalTrials.gov (NCT03194308); Pre-results.
Keyphrases